|
TNRC18 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.39919999999572E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.097670E-03 |
| Normal-vs-Stage2 |
1.439150E-03 |
| Normal-vs-Stage3 |
2.36389999999087E-05 |
| Normal-vs-Stage4 |
1.042380E-03 |
| Stage1-vs-Stage2 |
3.630400E-01 |
| Stage1-vs-Stage3 |
1.793970E-01 |
| Stage1-vs-Stage4 |
6.227600E-01 |
| Stage2-vs-Stage3 |
9.612200E-01 |
| Stage2-vs-Stage4 |
6.598000E-01 |
| Stage3-vs-Stage4 |
5.243600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.03489999999196E-05 |
| Normal-vs-AfricanAmerican |
2.154200E-01 |
| Normal-vs-Asian |
2.176200E-01 |
| Caucasian-vs-AfricanAmerican |
7.354100E-02 |
| Caucasian-vs-Asian |
7.500800E-01 |
| AfricanAmerican-vs-Asian |
4.558400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.17219999951868E-07 |
| Normal-vs-Female |
2.953700E-02 |
| Male-vs-Female |
6.010500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.726400E-02 |
| Normal-vs-Age(41-60Yrs) |
9.637600E-04 |
| Normal-vs-Age(61-80Yrs) |
5.54710000000291E-05 |
| Normal-vs-Age(81-100Yrs) |
2.025000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.854800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.059200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.110600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.586600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.766780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.769600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.902040E-02 |
| Normal-vs-Grade 2 |
2.044100E-03 |
| Normal-vs-Grade 3 |
2.19589999994607E-06 |
| Normal-vs-Grade 4 |
3.89330000000188E-05 |
| Grade 1-vs-Grade 2 |
2.41139999999085E-05 |
| Grade 1-vs-Grade 3 |
2.32459999999213E-05 |
| Grade 1-vs-Grade 4 |
2.11849999999236E-05 |
| Grade 2-vs-Grade 3 |
1.246960E-01 |
| Grade 2-vs-Grade 4 |
1.129650E-01 |
| Grade 3-vs-Grade 4 |
6.681800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.387450E-04 |
| Normal-vs-ccB subtype |
1.68350999999456E-05 |
| ccA subtype-vs-ccB subtype |
2.233200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.812000E-04 |
| Normal-vs-N1 |
7.240200E-02 |
| N0-vs-N1 |
8.681400E-01 |
|
|
